scorecardresearch
Add as a preferred source on Google
Friday, April 3, 2026
TopicPharmacy

Topic: pharmacy

US DEA shuts down 200-plus India-linked online pharmacies selling fentanyl-laced counterfeit pills

Federal agency fighting drug trafficking adds that it is actively collaborating with Indian officials to 'identify, investigate, and dismantle dangerous criminal organisations.'

India has a medicine problem — unregulated ‘innovation’

Overuse and misuse of antibiotics leads to antibiotic resistance. India has one of the highest antibiotic resistance rates, estimated to be growing by 5%-10% annually.

No new pharmacy colleges or seat addition until 2022 as Modi govt reviews demand

AICTE move seeks to address the concerns over employability of pharmacy graduates. There are 2,694 pharmacy colleges in the country.

New medicine that can cure flu in just one day gets US drug regulator’s nod

Compared to Tamiflu that requires two doses daily for 5 days, now a single dose of Xofluza can cure the illness. New drug to reach Indian markets in 2-3 years.

Banning 328 ‘cocktail’ drugs not a witch hunt, says officer behind the crackdown

Singh, who was responsible for DGCI move, says ban will not hurt the pharma brands or India’s larger pharma market.

Pioneer sees gene-editing therapy in your local clinic in five to 10 years

Concerns remain about the safety of disrupting or repairing defective genes, but experts say they are not a 'show-stopper'

Pfizer’s Viagra patent set to end in the US, Indian pharma firms sense huge opportunity

Seven get FDA approval to produce the drug, could send prices crashing in the US by nearly 99%.

On Camera

The real risk in a ground operation in Iran. It’s not about US capability

Iran is not unfamiliar terrain for US planners. The scenario has been war-gamed for decades. But control of territory does not equate to control of the conflict.

Tanker with 600,000 barrels of Iranian crude shifts course from India to China midway

The shipment earlier bound for Gujarat’s Vadinar has changed course amid payment concerns; could still reach India if issues are resolved, according to Kpler.

India commissions its third nuclear-powered ballistic missile submarine—INS Aridhaman

INS Arihant was first vessel under SSBN project and was quietly commissioned in 2016. The second indigenous SSBN, INS Arighat, was commissioned in August 2024.

Gulf war exposed India’s fragilities. It’s time for navel-gazing, in the national interest

It’s easy to understand why the government can’t speak the hard truth. When this war ends, as all wars do, India’s interests will lie with both the winner and the loser.